Affordable Access

Publisher Website

Isolation of Hafnia paralvei co-harbouring blaNDM-1 and blaVIM-1 in a woman who underwent allogeneic hematopoietic stem cell transplantation.

Authors
  • Appel, Tobias Manuel1, 2
  • Stein, Claudia3
  • Brandt, Christian3
  • Rödel, Jürgen4
  • Frietsch, Jochen J5
  • Miethke, Jenny5
  • Hochhaus, Andreas5
  • Hilgendorf, Inken5
  • 1 Klinik für Innere Medizin II, Abteilung für Hämatologie und internistische Onkologie, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany. [email protected]. , (Germany)
  • 2 Medizinische Klinik 2, Infektiologie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. [email protected]. , (Germany)
  • 3 Institut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany. , (Germany)
  • 4 Institut für Medizinische Mikrobiologie, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany. , (Germany)
  • 5 Klinik für Innere Medizin II, Abteilung für Hämatologie und internistische Onkologie, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany. , (Germany)
Type
Published Article
Journal
Infection
Publisher
Springer-Verlag
Publication Date
Aug 01, 2023
Volume
51
Issue
4
Pages
1161–1164
Identifiers
DOI: 10.1007/s15010-022-01976-8
PMID: 36595211
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Metallo-β-lactamases (MBL) are a threat to public health, since they dramatically limit the use of β-lactams. We report the isolation of a multidrug-resistant Hafnia paralvei strain from urine and a rectal swab of a female patient after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome. Antimicrobial susceptibility testing yielded resistance to trimethoprim/sulfamethoxazole, colistin, fosfomycin and all β-lactams, except cefiderocol. Whole genome sequencing revealed the presence of plasmid-encoded NDM-1 and VIM-1 carbapenemases. This finding highlights the importance of epidemiological surveillance and new therapeutic options for MBL. © 2023. The Author(s).

Report this publication

Statistics

Seen <100 times